Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

This FDA News Month in Review provides a round-up of regulatory decisions from April 2025.


FDA News Recap: April 2025

Simple choices like improving diet and increasing exercise can influence a healthy individual’s risk of developing cardiovascular disease.

Study Indicates Lifestyle Choices are Correlated with Cardiovascular Disease Risk

Bhatt discusses his expectations for the future of cardiology in 2025, including GLP-1-RAs and the push towards combination therapy.

GLP-1 RAs and the Move to Combination Therapy in 2025, with Ankeet Bhatt, MD, MBA

Ruff discusses his expectations for cardiology for the rest of 2025, including new research into GLP-1 receptor agonists.

GLP-1 RAs and the Future of Cardiology, with Christian Ruff, MD, MPH

Le discusses his anticipation for the results of upcoming cardiology trials in 2025, including HORIZON and Target-D.

Latest in Lipids and Trials to Watch in 2025, with Viet Le, DMSc, PA-C

Our Q1 2025 recap for cardiology spotlights 6 regulatory updates, 5 key trial announcements, and top expert perspectives in cardiac care.



Q1 2025 Recap: Cardiology News and Updates

This FDA News Month in Review provides a round-up of regulatory decisions from March 2025.


FDA News Recap: March 2025

FARES-II trial shows 4-factor PCC is safer, reduces bleeding, transfusions, and complications vs frozen plasma in cardiac surgery.

PCC Outperforms Frozen Plasma in Cardiac Surgery Bleeding Control

Data from the REVERSE-IT trial provide vital insight into the efficacy and safety of bentracimab as an FDA decision looms on the horizon. 

REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects

OAC-naive patients experienced a significantly smaller increase in stroke or systemic embolism with asundexian than apixaban.

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.